Actively Recruiting
Prospective Observational Study of Biomarkers and Progression in Mild Cognitive Impairment and Dementia
Led by Xuanwu Hospital, Beijing · Updated on 2026-10-15
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, longitudinal observational cohort study to examine clinical, cognitive, blood-based, and neuroimaging features across the spectrum of cognitive health. The study aims to distinguish stages of cognitive decline and predict progression from mild cognitive impairment MCI to dementia. It includes 600 participants divided into three groups cognitively unimpaired individuals, those with MCI, and those with dementia, further characterized by Alzheimers disease-related and non-Alzheimers subtypes. Participants will undergo evaluations including clinical assessments, neuropsychological testing, blood collection, and multimodal magnetic resonance imaging at baseline and again at 12 months. Blood analyses will measure established biomarkers like amyloid beta 42 and phosphorylated tau 217, as well as exploratory protein, microRNA, and lipid-metabolomic markers. Genetic testing for apolipoprotein E genotype will also be performed. No treatment is assigned during the study. Throughout the study, researchers will monitor cognitive performance, biomarker levels, and neuroimaging changes to compare profiles across groups and examine their relationships. Advanced statistical and machine learning methods will integrate these data to create diagnostic and risk-prediction models for MCI, dementia, and progression from MCI to dementia. The full study lasts at least 12 months with follow-up assessments at that time.
CONDITIONS
Brief Title
A Prospective Cohort Study of Multimodal Biomarkers and Progression From Mild Cognitive Impairment to Dementia
Research Team
Q
Qi Qin, MD, PhD
X
Xinyi Xia, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here